Market Research Logo

World OTC Pharmaceutical Markets: Self-Medication, Developing and Petro-Based Economies, BTC and Other Growth Trends


Attention: There is an updated edition available for this report.

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY
  • Background
  • Scope and Methodology
  • Size and Growth of the Market
  • Key Issues and Trends Affecting Market
  • Leading Competitors
CHAPTER TWO: INTRODUCTION
  • Background
  • Distribution and Safety Issues in the United States
  • Consumer Advertising/Promotion
  • World Health and Life Expectancy
    • Life Expectancy
    • Birth Rates
    • Tobacco Use
    • Obesity
  • Declining Growth of the World Population
  • Prescription VS Over-the-Counter Industry
    • Rx-to-OTC Switch Industry
    • Rx-to-OTC Switch Forecast in the United States
    • Economic Trends
      • Purchasing Power Trends
      • Challenges
    • Health Insurance Issues and Trends
    • Consumer Issues and Trends
      • U.S Consumers
      • Consumers around the World
    • Access to Professional Medical Services and the Link to Self-Medication
    • Regulatory Environment
      • Revisions to Pharmaceutical Affairs Law (PAL) in Japan
      • Russian Beneficiary Drug Provision Program
      • A Third Class of Drugs in the United States
CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA
    Overview
  • Demographics
  • OTC Product Segments
  • Market Analysis
  • OTC Product Segment Market Analysis
  • Markets by Country
CHAPTER FOUR: OTC MARKETS IN EUROPE
  • Overview
  • Demographics
  • OTC Product Segment
  • Market Analysis
  • OTC Product Segment Market Analysis
  • Markets by Country
CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA
  • Overview
  • Demographics
  • OTC Product Segments
  • Market Analysis
  • OTC Product Segment Market Analysis
  • Markets by Country
CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA
  • Overview
  • Demographics
  • OTC Product Segments
  • Market Analysis
    • OTC Product Segment Market Analysis
    • Markets by Country
CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS
  • Overview
    • OTC Product Segment Market Analysis
    • Markets by Country
CHAPTER EIGHT: LEADING OTC MANUFACTURERS
  • Overview
  • Competitor Analysis
  • Significant Mergers and Acquisitions
  • Bristol-Myers Squibb and Novartis AG
  • Johnson & Johnson and Pfizer
  • Bayer and Roche
  • Reckitt Benckiser and Adams Respiratory Therapeutics
  • Reckitt Benckiser and Boots Healthcare
  • Leading Corporate Profiles
  • Bayer Healthcare AG
  • Boehringer Ingelheim Gmbh
  • Chattem, Inc.
  • Glaxo Smith Kline
  • Mc Neil Consumer (Johnson & Johnson)
  • Novartis Consumer
  • Procter & Gamble
  • Reckitt Benckiser
  • Sanofi-Aventis
  • Schering-Plough
  • Taisho Pharmaceutical
  • Takeda Pharmaceutical
  • Wyeth
APPENDIX: LIST OF MAJOR COMPANIES

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY
  • Table 1-1: Total World OTC Market Analysis, 2005-2007
  • Table 1-2: Forecasted Total World OTC Market Analysis: 2008-2012
  • Figure 1-1: Total World OTC Market Analysis: 2005-2012
CHAPTER TWO: INTRODUCTION
  • Table 2-1: Average Life Expectancy in Years by Country 1980, 2004 and Estimated 2006
  • Table 2-2: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010
  • Figure 2-1: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010
  • Table 2-3: Percent of Smokers by Country
  • Figure 2-2: Average Percent of Smokers Worldwide in Developed Regions
  • Table 2-4: Percent of Population that is Obese* in 2003, 2004 and Estimated 2005
  • Table 2-5: World Population 1980 to 2050
  • Figure 2-3: World Population 1980 to 2050
  • Table 2-6: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Region, 2007
  • Figure 2-4: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Region, 2007
  • Table 2-7: Leading FDA Approved Rx-to-OTC Switches, 1994-2007
  • Figure 2-5: Number of New Rx-to-OTC Switches in the United States, per Year 1976-2007
  • Table 2-8: Potential Rx-to-OTC Switches, 2008-2013
  • Table 2-9: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
  • Figure 2-6: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
  • Table 2-10: Gross National Income Comparison by Country 2000-2005
  • Figure 2-7: Gross National Income Growth by Country 2000-2005
  • Table 2-11: National Healthcare Expenditures in the United States 1960-2010
  • Figure 2-8: Healthcare Spending as a Percent of GDP in the United States
  • Table 2-12: Health Insurance Trends in the United States 2003-2006
  • Figure 2-9: Typical Pharmacist-Consumer OTC Drug Counseling Session
CHAPTER THREE: OTC MARKETS IN ASIA- PACIFIC AND AFRICA
  • Table 3-1: Population by Age Group for the Five Most Populated Countries in Asia-Pacific, Estimated 2007
  • Table 3-2: Population by Age Group for the Five Most Populated Countries in Asia-Pacific, Projected 2012
  • Figure 3-1: Population for the Five Most Populated Countries in Asia-Pacific, Estimated 2007 and Projected 2012
  • Table 3-3: Population by Age Group for Africa, Estimated 2007 and 2012
  • Figure 3-2: Population for Africa, Estimated 2007 and Projected 2012
  • Table 3-4: Population by Gender for the Five Most Populated Countries in Asia-Pacific, Estimated 2007 and Projected 2012
  • Figure 3-3: Population by Gender for Asia-Pacific, Estimated 2007 and Projected 2012
  • Table 3-5: Population by Gender for Africa, Estimated 2007 and Projected 2012
  • Figure 3-4: Population by Gender for Africa, Estimated 2007 and Projected 2012
  • Table 3-6: Examples of Marketed OTC Products in Asia-Pacific and Africa (Product Name by Type and Marketer)
  • Table 3-7: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2007 and 2012
  • Figure 3-5: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2007
  • Figure 3-6: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2012
  • Table 3-8: Asia-Pacific/Africa OTC Market Analysis, 2005-2007
  • Table 3-9: Forecasted Asia-Pacific/Africa OTC Market Analysis: 2008-2012
  • Figure 3-7: Asia-Pacific/Africa OTC Market Analysis: 2005-2012
  • Table 3-10: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2007
  • Table 3-11: Forecasted Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2008-2012
  • Figure 3-8: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2012
  • Figure 3-9: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2007
  • Table 3-12: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2007
  • Figure 3-10: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2007
CHAPTER FOUR: OTC MARKETS IN EUROPE
  • Table 4-1: Population by Age for the Five Most Populated Countries in Europe, Estimated 2007
  • Table 4-2: Population by Age for the Five Most Populated Countries in Europe, Projected 2012
  • Figure 4-1: Population for the Five Most Populated Countries in Europe, Estimated 2007 and Projected 2012
  • Table 4-3: Population by Gender for the Five Most Populated Countries in Europe, Estimated 2007 and Projected 2012
  • Figure 4-2: Population by Gender for Europe, Estimated 2007 and Projected 2012
  • Table 4-4: Examples of Marketed OTC Products in Europe (Product Name by Type and Marketer)
  • Table 4-5: European OTC Market as a Percentage of World Market, 2007 and 2012
  • Figure 4-3: European OTC Market as a Percentage of World Market, 2007
  • Figure 4-4: European OTC Market as a Percentage of World Market, 2012
  • Table 4-6: European OTC Market Analysis, 2005-2007
  • Table 4-7: Forecasted European OTC Market Analysis: 2008-2012
  • Figure 4-5: European OTC Market Analysis: 2005-2012
  • Table 4-8: European OTC Market Analysis by Product Segment, 2005-2007
  • Table 4-9: Forecasted European OTC Market Analysis by Product Segment, 2008-2012
  • Figure 4-6: European OTC Market Analysis by Product Segment, 2005-2012
  • Figure 4-7: European OTC Market Analysis by Product Segment, 2007
  • Table 4-10: European OTC Market Analysis by Selected Country, 2007
  • Figure 4-8: European OTC Market Analysis by Selected Country, 2007
CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA
  • Table 5-1: Population by Age for the Five Most Populated Countries in North America, Estimated 2007
  • Table 5-2: Population by Age for the Five Most Populated Countries in North America, Projected 2012
  • Figure 5-1: Population for the Five Most Populated Countries in North America, Estimated 2007 and Projected 2012
  • Table 5-3: Population by Gender for the Five Most Populated Countries in North America, Estimated 2007 and Projected 2012
  • Figure 5-2: Population by Gender for North America, Estimated 2007 and Projected 2012
  • Table 5-4: Examples of Marketed OTC Products in North America (Product Name by Type and Marketer)
  • Table 5-5: North American OTC Market as a Percentage of World Market, 2007 and 2012
  • Figure 5-3: North American OTC Market as a Percentage of World Market, 2007
  • Figure 5-4: North American OTC Market as a Percentage of World Market, 2012
  • Table 5-6: North American OTC Market Analysis, 2005-2007
  • Table 5-7: Forecasted North American OTC Market Analysis: 2008-2012
  • Figure 5-5: North American OTC Market Analysis: 2005-2012
  • Table 5-8: North American OTC Market Analysis by Product Segment, 2005-2007
  • Table 5-9: Forecasted North American OTC Market Analysis by Product Segment, 2008-2012
  • Figure 5-6: North American OTC Market Analysis | by Product Segment, 2005-2012
  • Figure 5-7: North American OTC Market Analysis by Product Segment, 2007
  • Table 5-10: North American OTC Market Analysis by Selected Country, 2007
  • Figure 5-8: North American OTC Market Analysis by Selected Country, 2007
CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA
  • Table 6-1: Population by Age for the Five Most Populated Countries in South America, Estimated 2007
  • Table 6-2: Population by Age for the Five Most Populated Countries in South America, Projected 2012
  • Figure 6-1: Population for the Five Most Populated Countries in South America, Estimated 2007 and Projected 2012
  • Table 6-3:Population by Gender for the Five Most Populated Countries in South America, Estimated 2007 and Projected 2012
  • Figure 6-2: Population by Gender for South America, Estimated 2007 and Projected 2012
  • Table 6-4: Examples of Marketed OTC Products in South America (Product Name by Type and Marketer)
  • Table 6-5: South American OTC Market as a Percentage of World Market, 2007 and 2012
  • Figure 6-3: South American OTC Market as a Percentage of World Market, 2007
  • Figure 6-4: South American OTC Market as a Percentage of World Market, 2012
  • Table 6-6: South American OTC Market Analysis, 2005-2007
  • Table 6-7: Forecasted South American OTC Market Analysis: 2008-2012
  • Figure 6-5: South American OTC Market Analysis: 2005-2012
  • Table 6-8: South American OTC Market Analysis by Product Segment, 2005-2007
  • Table 6-9: Forecasted South American OTC Market Analysis by Product Segment, 2008-2012
  • Figure 6-6: South American OTC Market Analysis by Product Segment, 2005-2012
  • Figure 6-7: South American OTC Market Analysis by Product Segment, 2007
  • Table 6-10: South American OTC Market Analysis by Selected Country, 2007
  • Figure 6-8: South American OTC Market Analysis by Selected Country, 2007
CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS
  • Table 7-1: Total World OTC Market Analysis, 2005-2007
  • Table 7-2: Forecasted Total World OTC Market Analysis: 2008-2012
  • Figure 7-1: Total World OTC Market Analysis: 2005-2012
  • Table 7-3: Total World OTC Market Analysis by Product Segment, 2005-2007
  • Table 7-4: Forecasted Total World OTC Market Analysis by Product Segment, 2008-2012
  • Figure 7-2: Total World OTC Market Analysis by Product Segment, 2005-2012
  • Figure 7-3: Total World OTC Market Analysis by Product Segment, 2007
  • Figure 7-4: Total World OTC Market Analysis by Product Segment, 2012
  • Table 7-5: Top Ten World OTC Markets by Country, 2007
  • Figure 7-5: Top Ten World OTC Markets by Country, 2007
CHAPTER EIGHT: LEADING OTC MANUFACTURERS
  • Table 8-1: Leading Suppliers Shares of the OTC Market and Significant Segments of Participation, 2007
  • Figure 8-1: Leading Suppliers Shares of the OTC Market, 2007

Over-the-counter (OTC) drugs are well situated to capitalize on worldwide economic conditions. Customers in the US and in the world under time constraints and tight budgets prefer OTC and are opting to self-medicate where possible. Developing and petro-rich nations are pushing world demand for pharmaceuticals. Pharmacists are favoring OTCs, and are a driving force behind a new class of 'behind the counter' (BTC) drugs. The aging of the population and an increase in medical conditions generally continues to bode well for OTC products. For the purpose of this study, Kalorama Information has divided products into five general segments:

  • Analgesics
  • Allergy, Cough, Cold, Flu Remedies
  • Gastrointestinal Remedies
  • Dermatologics
  • Others (including: Smoking cessation products, Sleepaids, Dental rinses, fluorides, Hair growth remedies, Diet aids)
As part of thorough coverage of the OTC market, this report includes:
  • Current Market Size and Forecasts by Product Type
  • Regional Breakout of Revenues (including Asia Pacific and Africa, Europe, North America, South America regions)
  • The Combined Wisdom of over 100 Market Experts interviewed for This Report
  • Over 110 Figures and Tables to Make Points in the Text Clear
  • Overview of Over the Counter Market
  • Review of Successful OTC Products
  • Market Share
  • Company Profiles
  • Discussion of Issues and Trends in OTC
Knowledge of issues affecting the world market for OTC drugs are critical to understanding this market and this report tackles the following issues and trends:
  • Consumer Advertising and Promotion
  • Demographics
  • Prescription vs. OTC Industry
  • Rx-to-OTC Switch Industry
  • Economic Trends
  • Health Insurance Issues and Trends
  • Consumer Issues and Trends
  • Regulatory Environment

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 100 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

The OTC market is vast with many competitors. The following main competitors are profiled in this report:

  • Abbott Laboratories
  • Novartis
  • Wyeth
  • Bayer Consumer Health
  • Boehringer Ingelheim
  • Chattem
  • GlaxoSmithKline
  • McNeil Consumer (Johnson & Johnson)
  • Novartis Pharmaceuticals
  • Procter & Gamble
  • Reckitt Benckiser
  • Sanofi-Aventis
  • Schering-Plough
  • Taisho Pharmaceutical
  • Takeda
  • Wyeth Consumer


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;